Michael Scolaro

Michael Scolaro

Oct 30, 2017

Group 6 Copy 196
4
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

Evaluating the Nutritional Status in Captive Saddle-billed Storks

Saddle-billed Storks are large, charismatic birds that are rare in captivity. The Dallas Zoo was the first zoo...

Targeting the Hypoxic Response in Multiple Myeloma Cells Engrafted in the Bone Marrow

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing...

Backer Badge Funded